Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
Ting Shi,David A McAllister,Katherine L O'Brien,Eric A F Simoes,Shabir A Madhi,Bradford D Gessner,Fernando P Polack,Evelyn Balsells,Sozinho Acacio,Claudia Aguayo,Issifou Alassani,Asad Ali,Martin Antonio,Shally Awasthi,Juliet O Awori,Eduardo Azziz-Baumgartner,Henry C Baggett,Vicky L Baillie,Angel Balmaseda,Alfredo Barahona,Sudha Basnet,Quique Bassat,Wilma Basualdo,Godfrey Bigogo,Louis Bont,Robert F Breiman,W Abdullah Brooks,Shobha Broor,Nigel Bruce,Dana Bruden,Philippe Buchy,Stuart Campbell,Phyllis Carosone-Link,Mandeep Chadha,James Chipeta,Monidarin Chou,Wilfrido Clara,Cheryl Cohen,Elizabeth de Cuellar,Duc-Anh Dang,Budragchaagiin Dash-Yandag,Maria Deloria-Knoll,Mukesh Dherani,Tekchheng Eap,Bernard E Ebruke,Marcela Echavarria,Carla Cecília de Freitas Lázaro Emediato,Rodrigo A Fasce,Daniel R Feikin,Luzhao Feng,Angela Gentile,Aubree Gordon,Doli Goswami,Sophie Goyet,Michelle Groome,Natasha Halasa,Siddhivinayak Hirve,Nusrat Homaira,Stephen R C Howie,Jorge Jara,Imane Jroundi,Cissy B Kartasasmita,Najwa Khuri-Bulos,Karen L Kotloff,Anand Krishnan,Romina Libster,Olga Lopez,Marilla G Lucero,Florencia Lucion,Socorro P Lupisan,Debora N Marcone,John P McCracken,Mario Mejia,Jennifer C Moisi,Joel M Montgomery,David P Moore,Cinta Moraleda,Jocelyn Moyes,Patrick Munywoki,Kuswandewi Mutyara,Mark P Nicol,D James Nokes,Pagbajabyn Nymadawa,Maria Tereza da Costa Oliveira,Histoshi Oshitani,Nitin Pandey,Gláucia Paranhos-Baccalà,Lia N Phillips,Valentina Sanchez Picot,Mustafizur Rahman,Mala Rakoto-Andrianarivelo,Zeba A Rasmussen,Barbara A Rath,Annick Robinson,Candice Romero,Graciela Russomando,Vahid Salimi,Pongpun Sawatwong,Nienke Scheltema,Brunhilde Schweiger,J Anthony G Scott,Phil Seidenberg,Kunling Shen,Rosalyn Singleton,Viviana Sotomayor,Tor A Strand,Agustinus Sutanto,Mariam Sylla,Milagritos D Tapia,Somsak Thamthitiwat,Elizabeth D Thomas,Rafal Tokarz,Claudia Turner,Marietjie Venter,Sunthareeya Waicharoen,Jianwei Wang,Wanitda Watthanaworawit,Lay-Myint Yoshida,Hongjie Yu,Heather J Zar,Harry Campbell,Harish Nair,RSV Global Epidemiology Network
DOI: https://doi.org/10.1016/S0140-6736(17)30938-8
2017-09-02
Abstract:Background: We have previously estimated that respiratory syncytial virus (RSV) was associated with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in 55 000 to 199 000 deaths in children younger than 5 years in 2005. In the past 5 years, major research activity on RSV has yielded substantial new data from developing countries. With a considerably expanded dataset from a large international collaboration, we aimed to estimate the global incidence, hospital admission rate, and mortality from RSV-ALRI episodes in young children in 2015. Methods: We estimated the incidence and hospital admission rate of RSV-associated ALRI (RSV-ALRI) in children younger than 5 years stratified by age and World Bank income regions from a systematic review of studies published between Jan 1, 1995, and Dec 31, 2016, and unpublished data from 76 high quality population-based studies. We estimated the RSV-ALRI incidence for 132 developing countries using a risk factor-based model and 2015 population estimates. We estimated the in-hospital RSV-ALRI mortality by combining in-hospital case fatality ratios with hospital admission estimates from hospital-based (published and unpublished) studies. We also estimated overall RSV-ALRI mortality by identifying studies reporting monthly data for ALRI mortality in the community and RSV activity. Findings: We estimated that globally in 2015, 33·1 million (uncertainty range [UR] 21·6-50·3) episodes of RSV-ALRI, resulted in about 3·2 million (2·7-3·8) hospital admissions, and 59 600 (48 000-74 500) in-hospital deaths in children younger than 5 years. In children younger than 6 months, 1·4 million (UR 1·2-1·7) hospital admissions, and 27 300 (UR 20 700-36 200) in-hospital deaths were due to RSV-ALRI. We also estimated that the overall RSV-ALRI mortality could be as high as 118 200 (UR 94 600-149 400). Incidence and mortality varied substantially from year to year in any given population. Interpretation: Globally, RSV is a common cause of childhood ALRI and a major cause of hospital admissions in young children, resulting in a substantial burden on health-care services. About 45% of hospital admissions and in-hospital deaths due to RSV-ALRI occur in children younger than 6 months. An effective maternal RSV vaccine or monoclonal antibody could have a substantial effect on disease burden in this age group. Funding: The Bill & Melinda Gates Foundation.